<?xml version="1.0" encoding="UTF-8"?>
<p>The anti-cancer ferutinin activity was also evaluated in vivo, in comparison with cisplatin, on tumors developed in hybrid BALB/C mice: a tumor reduction of 67% for ferutinin and of 72% for cisplatin was observed; however while the latter produced a significant alteration of the liver tissues and the spleen of the treated mice, this did not happen for mice in treatment with ferutinin [
 <xref rid="B95-molecules-25-05768" ref-type="bibr">95</xref>]. 
</p>
